Cargando…

Retraction Note: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients

Detalles Bibliográficos
Autores principales: Luo, Yushuang, Li, Zhanquan, Cui, Sen, Shen, Cunfang, Zhao, Junhui, Wu, Milu, Li, Yuying, Wang, Miaozhou, Chen, Rong, Liu, Zhibo, Ri-li, Ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374186/
https://www.ncbi.nlm.nih.gov/pubmed/25888862
http://dx.doi.org/10.1186/s40001-015-0134-4
_version_ 1782363441158160384
author Luo, Yushuang
Li, Zhanquan
Cui, Sen
Shen, Cunfang
Zhao, Junhui
Wu, Milu
Li, Yuying
Wang, Miaozhou
Chen, Rong
Liu, Zhibo
Ri-li, Ge
author_facet Luo, Yushuang
Li, Zhanquan
Cui, Sen
Shen, Cunfang
Zhao, Junhui
Wu, Milu
Li, Yuying
Wang, Miaozhou
Chen, Rong
Liu, Zhibo
Ri-li, Ge
author_sort Luo, Yushuang
collection PubMed
description
format Online
Article
Text
id pubmed-4374186
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43741862015-03-27 Retraction Note: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients Luo, Yushuang Li, Zhanquan Cui, Sen Shen, Cunfang Zhao, Junhui Wu, Milu Li, Yuying Wang, Miaozhou Chen, Rong Liu, Zhibo Ri-li, Ge Eur J Med Res Retraction Note BioMed Central 2015-03-26 /pmc/articles/PMC4374186/ /pubmed/25888862 http://dx.doi.org/10.1186/s40001-015-0134-4 Text en © Luo et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Retraction Note
Luo, Yushuang
Li, Zhanquan
Cui, Sen
Shen, Cunfang
Zhao, Junhui
Wu, Milu
Li, Yuying
Wang, Miaozhou
Chen, Rong
Liu, Zhibo
Ri-li, Ge
Retraction Note: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients
title Retraction Note: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients
title_full Retraction Note: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients
title_fullStr Retraction Note: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients
title_full_unstemmed Retraction Note: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients
title_short Retraction Note: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients
title_sort retraction note: joint detection of ercc1, tubb3, and tyms guidance selection of docetaxel, 5-fluorouracil and cisplatin (ddp) individual chemotherapy in advanced gastric cancer patients
topic Retraction Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374186/
https://www.ncbi.nlm.nih.gov/pubmed/25888862
http://dx.doi.org/10.1186/s40001-015-0134-4
work_keys_str_mv AT luoyushuang retractionnotejointdetectionofercc1tubb3andtymsguidanceselectionofdocetaxel5fluorouracilandcisplatinddpindividualchemotherapyinadvancedgastriccancerpatients
AT lizhanquan retractionnotejointdetectionofercc1tubb3andtymsguidanceselectionofdocetaxel5fluorouracilandcisplatinddpindividualchemotherapyinadvancedgastriccancerpatients
AT cuisen retractionnotejointdetectionofercc1tubb3andtymsguidanceselectionofdocetaxel5fluorouracilandcisplatinddpindividualchemotherapyinadvancedgastriccancerpatients
AT shencunfang retractionnotejointdetectionofercc1tubb3andtymsguidanceselectionofdocetaxel5fluorouracilandcisplatinddpindividualchemotherapyinadvancedgastriccancerpatients
AT zhaojunhui retractionnotejointdetectionofercc1tubb3andtymsguidanceselectionofdocetaxel5fluorouracilandcisplatinddpindividualchemotherapyinadvancedgastriccancerpatients
AT wumilu retractionnotejointdetectionofercc1tubb3andtymsguidanceselectionofdocetaxel5fluorouracilandcisplatinddpindividualchemotherapyinadvancedgastriccancerpatients
AT liyuying retractionnotejointdetectionofercc1tubb3andtymsguidanceselectionofdocetaxel5fluorouracilandcisplatinddpindividualchemotherapyinadvancedgastriccancerpatients
AT wangmiaozhou retractionnotejointdetectionofercc1tubb3andtymsguidanceselectionofdocetaxel5fluorouracilandcisplatinddpindividualchemotherapyinadvancedgastriccancerpatients
AT chenrong retractionnotejointdetectionofercc1tubb3andtymsguidanceselectionofdocetaxel5fluorouracilandcisplatinddpindividualchemotherapyinadvancedgastriccancerpatients
AT liuzhibo retractionnotejointdetectionofercc1tubb3andtymsguidanceselectionofdocetaxel5fluorouracilandcisplatinddpindividualchemotherapyinadvancedgastriccancerpatients
AT rilige retractionnotejointdetectionofercc1tubb3andtymsguidanceselectionofdocetaxel5fluorouracilandcisplatinddpindividualchemotherapyinadvancedgastriccancerpatients